These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 30273348

  • 1. In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm.
    Pollini S, Di Pilato V, Landini G, Di Maggio T, Cannatelli A, Sottotetti S, Cariani L, Aliberti S, Blasi F, Sergio F, Rossolini GM, Pallecchi L.
    PLoS One; 2018; 13(10):e0203941. PubMed ID: 30273348
    [Abstract] [Full Text] [Related]

  • 2. The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms.
    Caraher EM, Gumulapurapu K, Taggart CC, Murphy P, McClean S, Callaghan M.
    J Antimicrob Chemother; 2007 Sep; 60(3):546-54. PubMed ID: 17595284
    [Abstract] [Full Text] [Related]

  • 3. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
    Ratjen A, Yau Y, Wettlaufer J, Matukas L, Zlosnik JE, Speert DP, LiPuma JJ, Tullis E, Waters V.
    Antimicrob Agents Chemother; 2015 Jan; 59(1):711-3. PubMed ID: 25348526
    [Abstract] [Full Text] [Related]

  • 4. In Vitro Synergism of Colistin and N-acetylcysteine against Stenotrophomonas maltophilia.
    Ciacci N, Boncompagni S, Valzano F, Cariani L, Aliberti S, Blasi F, Pollini S, Rossolini GM, Pallecchi L.
    Antibiotics (Basel); 2019 Jul 25; 8(3):. PubMed ID: 31349560
    [Abstract] [Full Text] [Related]

  • 5. Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.
    Wu K, Yau YC, Matukas L, Waters V.
    Antimicrob Agents Chemother; 2013 Mar 25; 57(3):1546-8. PubMed ID: 23295930
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria.
    Van Acker H, Van Snick E, Nelis HJ, Coenye T.
    J Cyst Fibros; 2010 Dec 25; 9(6):450-4. PubMed ID: 20851061
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression.
    Pompilio A, Crocetta V, Verginelli F, Di Bonaventura G.
    FEMS Microbiol Lett; 2016 Jul 25; 363(14):. PubMed ID: 27242375
    [Abstract] [Full Text] [Related]

  • 8. Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro.
    Caraher E, Reynolds G, Murphy P, McClean S, Callaghan M.
    Eur J Clin Microbiol Infect Dis; 2007 Mar 25; 26(3):213-6. PubMed ID: 17265071
    [Abstract] [Full Text] [Related]

  • 9. Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms.
    Kennedy S, Beaudoin T, Yau YC, Caraher E, Zlosnik JE, Speert DP, LiPuma JJ, Tullis E, Waters V.
    Antimicrob Agents Chemother; 2016 Jan 25; 60(1):348-55. PubMed ID: 26503664
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
    Nicholson A, Perry JD, James AL, Stanforth SP, Carnell S, Wilkinson K, Anjam Khan CM, De Soyza A, Gould FK.
    Int J Antimicrob Agents; 2012 Jan 25; 39(1):27-32. PubMed ID: 21993484
    [Abstract] [Full Text] [Related]

  • 11. Activity of N-Acetylcysteine Alone and in Combination with Colistin against Pseudomonas aeruginosa Biofilms and Transcriptomic Response to N-Acetylcysteine Exposure.
    Valzano F, Boncompagni SR, Micieli M, Di Maggio T, Di Pilato V, Colombini L, Santoro F, Pozzi G, Rossolini GM, Pallecchi L.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0100622. PubMed ID: 35735984
    [Abstract] [Full Text] [Related]

  • 12. Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex.
    Fraser-Pitt D, Mercer D, Lovie E, Robertson J, O'Neil D.
    Antimicrob Agents Chemother; 2016 Oct 31; 60(10):6200-6. PubMed ID: 27503654
    [Abstract] [Full Text] [Related]

  • 13. Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex.
    Ahmad S, Tyrrell J, Walton WG, Tripathy A, Redinbo MR, Tarran R.
    Antimicrob Agents Chemother; 2016 Oct 31; 60(10):6003-12. PubMed ID: 27458217
    [Abstract] [Full Text] [Related]

  • 14. Drug Resistance in Biofilm and Planktonic Cells of Achromobacter spp., Burkholderia spp., and Stenotrophomonas maltophilia Clinical Isolates.
    Montoya-Hinojosa EI, Villarreal-Treviño L, Bocanegra-Ibarias P, Camacho-Ortiz A, Flores-Treviño S.
    Microb Drug Resist; 2024 Sep 31; 30(9):354-362. PubMed ID: 39029506
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria.
    Peeters E, Nelis HJ, Coenye T.
    J Antimicrob Chemother; 2009 Oct 31; 64(4):801-9. PubMed ID: 19633000
    [Abstract] [Full Text] [Related]

  • 16. Effect of antimicrobials on Stenotrophomonas maltophilia biofilm.
    Santos Carvalhais BE, Souza E Silva C, Dos Santos KV.
    Future Microbiol; 2021 Jan 31; 16(2):83-93. PubMed ID: 33470844
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
    Cantón R, Valdezate S, Vindel A, Sánchez Del Saz B, Maíz L, Baquero F.
    Pediatr Pulmonol; 2003 Feb 31; 35(2):99-107. PubMed ID: 12526070
    [Abstract] [Full Text] [Related]

  • 18. N-acetylcysteine inhibits growth, adhesion and biofilm formation of Gram-positive skin pathogens.
    Eroshenko D, Polyudova T, Korobov V.
    Microb Pathog; 2017 Apr 31; 105():145-152. PubMed ID: 28237766
    [Abstract] [Full Text] [Related]

  • 19. Disruption of biofilms and killing of Burkholderia cenocepacia from cystic fibrosis lung using an antioxidant-antibiotic combination therapy.
    Aiyer A, Manoharan A, Paino D, Farrell J, Whiteley GS, Kriel FH, Glasbey TO, Manos J, Das T.
    Int J Antimicrob Agents; 2021 Aug 31; 58(2):106372. PubMed ID: 34116184
    [Abstract] [Full Text] [Related]

  • 20. In Vitro Activity of a Novel Glycopolymer against Biofilms of Burkholderia cepacia Complex Cystic Fibrosis Clinical Isolates.
    Narayanaswamy VP, Duncan AP, LiPuma JJ, Wiesmann WP, Baker SM, Townsend SM.
    Antimicrob Agents Chemother; 2019 Jun 31; 63(6):. PubMed ID: 30910901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.